Genentech, Constellation Enter Largest Epigenetics Tie-Up Yet
This article was originally published in The Pink Sheet Daily
Executive Summary
For $95 million guaranteed, Genentech gains rights to broad research in the emerging field over a three-year period, as well as an option to acquire the start-up outright.